Skip to main content
Log in

“Two-route chemotherapy” using high-dose intra-arterial neocarzinostatin and systemic tiopronin, its antidote, for rat limb tumor

  • Original Articles
  • Two-route Chemotherapy, Neocarzinostatin, Tiopronin
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

We studied the effect of “two-route chemotherapy” (TRC) with intra-arterial (IA) neocarzinostatin (NCS) and IV N-(2-mercaptopropionyl)-glycine (tiopronin), its antidote, on rat limb tumors. Chemotherapy experiments were carried out on day 9 after the inoculation of 106 syngeneic transitional carcinoma cells into the hind limb in female Wistar King A rats. In the group given TRC, 3500 units/kg NCS and 800 mg/kg tiopronin were given via the femoral artery and the femoral vein, respectively. The antitumor effect was evaluated by the tumor weight on day 12 after the treatment. Compared with the weight of tumors in untreated controls, TRC reduced tumor weight to one-tenth, while 700 units/kg IA NCS alone reduced tumor weight to one-third and 700 units/kg systemic NCS alone reduced tumor weight to three-fourths of the control weight. In the group given TRC, WBC and nucleated bone marrow cells were completely protected and loss of body weight was slight.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

NCS:

Neocarzinostatin

TRC:

two-route chemotherapy

References

  1. Baba T, Nishikawa K (1980) Effective combination of anti-cancer drug with its antidote for chemotherapy for hepatic metastasis. Gann 71: 157

    Google Scholar 

  2. Evans RG, Wheatley C, Engel C, Nielsen J, Ciborowski (1984) Modification of the bone marrow toxicity of cis-diamminedichloroplatinum (II) in mice by diethyldithiocarbamate. Cancer Res 44:3686

    Google Scholar 

  3. Finney DJ (1978) Statistical method in biological assay, 3rd edition. Macmillan, New York, p 370

    Google Scholar 

  4. Fujita H, Nakayama N, Sawabe T, Kimura K (1970) In vivo distribution and inactivation of neocarzinostatin. Jpn J Antibiot 23: 471 (in Japanese)

    Google Scholar 

  5. Hamada M, Nakamura N, Takashima R (1974) Studies on acceleration of mercury excretion by tiopronin. Igaku-no-Ayumi 91: 285 (in Japanese)

    Google Scholar 

  6. Howell SB, Taetle R (1980) Effect of sodium thiosulfate on cis-dichlorodiammineplatinum (II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 64: 611

    Google Scholar 

  7. Howell SB, Pfeifle CE, Wung WE, Olshen RA, Lucas WE, Yon JL, Green M (1982) Intraperitoneal cisplatin with systemic thiosulfate protection. Ann Intern Med 97: 845

    Google Scholar 

  8. Ichida F, Shibasaki K, Takino T, Suzuki H, Jujisawa K, Inoue K, Hirayama C, Kaito I, Hirasawa T, Kameda H, Inoue J, Satoh G, Kosaka Y, Yamamoto S, Nagashima H, Tsuji T, Ohta Y, Okada J (1982) Therapeutic effects of tiopronin on chronic hepatitis; A double-blind clinical study. J Intern Med Res 10: 325

    Google Scholar 

  9. Ishizawa M, Taniguchi S, Baba T (1981) Protection by sodium thiosulfate and thiourea against lethal toxicity of cis-diamminedichloroplatinum (II) in bacteria and mice. Jpn J Pharmacol 31: 883

    Google Scholar 

  10. Ito A, Koide Y, Haneda I, Toriyama K, Ouchi M, Matsumoto T, Baba T (1985) Screening for the antagonizing agents against lethal toxicity of neocarzinostatin: 1. Jpn J Antibiot 38: 137 (in Japanese)

    Google Scholar 

  11. Iwamoto Y, Kawano T, Uozumi J, Aoki K, Baba T (1984a) “Two-route chemotherapy” using high-dose ip cisplatin and IV sodium thiosulfate, its antidote, for peritoneally disseminated cancer in mice. Cancer Treat Rep 68: 1367

    Google Scholar 

  12. Iwamoto Y, Aoki K, Kawano T, Baba T (1984b) Upper hemibody infusion of cis-diamminedichloroplatinum (II) followed by systemin antidote, sodium thiosulfate, for lung metastasis in rats. Clin Exp Metastasis 2: 261

    Google Scholar 

  13. Iwamoto Y, Kawano T, Ishizawa M, Aoki K, Kuroiwa T, Baba T (1985) Inactivation of cis-diamminedichloroplatinum (II) in blood and protection of its toxicity by sodium thiosulfate in rabbits. Cancer Chemother Pharmacol 15: 228

    Google Scholar 

  14. Klopp CT, Alford TC, Bateman J, Berry GN, Winship T (1950) Fractionated intra-arterial cancer chemotherapy with methyl bis-amine hydrochloride. Ann Surg 132: 811

    Google Scholar 

  15. Koba F, Tsuji H, Abe R, Asoh T, Miyazaki S, Shirasaka C, Takeuchi Y, Arinaga S, Wada T, Uchida I, Akiyama T, Baba T (1983) Two-route-infusion chemotherapy for primary and metastatic liver cancer. Gan-to-kagakuryoho (Jpn J Cancer Chemother) 10: 1684 (in Japanese)

    Google Scholar 

  16. Lieberman HR (1983) Estimating LD50 using the Probit technique: a basic computer technique. Drug Chemical Toxicity 6: 111

    Google Scholar 

  17. Maeda H (1981) Neocarzionstatin in cancer chemotherapy (review) Anticancer Res 1: 175

    Google Scholar 

  18. Pavirk LF, Goldberg IH (1980) Binding of the nonprotein chromophore of neocarzinostatin to deoxyribonucleic acid. Biochemistry 19: 4773

    Google Scholar 

  19. Sagiyama K, Uozumi J, Aoki K, Baba T (1983) Efficacy of “two-route chemotherapy” using intra-arterial cisplatin and IV sodium thiosulfate, its antidote, in rat bladder tumor. Cancer Treat Rep 67: 567

    Google Scholar 

  20. Sakamoto S, Ogata J, Ikegami K, Maeda H (1980) Chemotherapy for bladder cancer with Neocarzinostatin: evaluation of systemic administration. Eur J Cancer 16: 103

    Google Scholar 

  21. Taniguchi S, Baba T (1982) “Two-route chemotherapy” using cis-diamminedichloroplatinum (II) and its antidote, sodium thiosulfate, for peritoneally disseminated cancer in rats. Gann 73: 475

    Google Scholar 

  22. Uozumi J, Sagiyama K, Aoki K, Iwamoto Y, Baba T (1983) Effectiveness of “two-route chemotherapy” using cisplatin and its antidote, sodium thiosulfate, on life span of rats bearing metastatic liver tumors. Cancer Treat Rep 67: 1067

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The work reported in this paper was supported by a Grant-in-Aid for cancer research from the Ministry of Education, Science and Culture, and by the Ministry of Health and Welfare, Japan

Rights and permissions

Reprints and permissions

About this article

Cite this article

Iwamoto, Y., Kuroiwa, T., Aoki, K. et al. “Two-route chemotherapy” using high-dose intra-arterial neocarzinostatin and systemic tiopronin, its antidote, for rat limb tumor. Cancer Chemother. Pharmacol. 17, 247–250 (1986). https://doi.org/10.1007/BF00256693

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00256693

Keywords

Navigation